SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Incyte Corporation (INCY) trades at a trailing P/E of 14.6, forward P/E of 13.3. Trailing earnings yield is 6.85%, forward earnings yield 7.54%. PEG 0.90 (Peter Lynch undervalued ≤1.0). Graham Number is $61.87.
Criteria proven by this page:
- VALUE (77/100, Pass) — P/E is below market average (14.6); PEG ≤ 1.0 — Peter Lynch undervalued (0.90); analyst target implies upside (+11.5%); earnings yield beats bond yields (6.85%).
- Forward P/E 13.3 (down from trailing 14.6) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.90 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 6.85% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income. Forward yield improves to 7.54% as earnings recover.
- Analyst consensus target $108.90 (+11.5% upside) — modest upside expected.
Overall SharesGrow Score: 82/100 with 6/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
77/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — INCY
Valuation Multiples
P/E (TTM)14.6
Forward P/E13.3
PEG Ratio0.90
Forward PEG0.90
P/B Ratio3.63
P/S Ratio3.68
EV/EBITDA9.0
Per Share Data
EPS (TTM)$6.52
Forward EPS (Est.)$7.36
Book Value / Share$26.11
Revenue / Share$26.04
FCF / Share$6.86
Yields & Fair Value
Earnings Yield6.85%
Forward Earnings Yield7.54%
Dividend Yield0.00%
Graham Number$61.87
SharesGrow IV$117.61 (+20.4%)
Analyst Target$108.90 (+11.5%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2016 |
180.7 |
0.14 |
44.91 |
17.04 |
- |
| 2017 |
-61.9 |
0.16 |
11.88 |
12.61 |
- |
| 2018 |
123.3 |
-0.92 |
7.01 |
7.18 |
- |
| 2019 |
42.0 |
0.14 |
7.22 |
8.69 |
- |
| 2020 |
-64.1 |
0.39 |
7.26 |
7.11 |
- |
| 2021 |
17.1 |
-0.04 |
4.29 |
5.42 |
- |
| 2022 |
52.3 |
-0.81 |
4.08 |
5.25 |
- |
| 2023 |
23.5 |
0.32 |
2.71 |
3.80 |
- |
| 2024 |
438.6 |
-4.67 |
4.15 |
3.37 |
- |
| 2025 |
15.0 |
0.00 |
3.73 |
3.75 |
- |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$0.54 |
$1.11B |
$104.22M |
9.4% |
| 2017 |
$-1.53 |
$1.54B |
$-313.14M |
-20.4% |
| 2018 |
$0.51 |
$1.88B |
$109.49M |
5.8% |
| 2019 |
$2.05 |
$2.16B |
$446.91M |
20.7% |
| 2020 |
$-1.36 |
$2.67B |
$-295.7M |
-11.1% |
| 2021 |
$4.27 |
$2.99B |
$948.58M |
31.8% |
| 2022 |
$1.52 |
$3.39B |
$340.66M |
10% |
| 2023 |
$2.65 |
$3.7B |
$597.6M |
16.2% |
| 2024 |
$0.15 |
$4.24B |
$32.62M |
0.8% |
| 2025 |
$6.41 |
$5.14B |
$1.29B |
25% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$7.43 |
$6.78 – $7.71 |
$5.57B |
$5.48B – $5.76B |
15 |
| 2027 |
$8.98 |
$8.01 – $11.10 |
$6.21B |
$5.81B – $7.32B |
15 |
| 2028 |
$9.61 |
$6.19 – $12.72 |
$6.49B |
$6.47B – $6.5B |
11 |
| 2029 |
$3.52 |
$3.32 – $4.06 |
$4.59B |
$4.39B – $5.13B |
4 |
| 2030 |
$4.03 |
$3.80 – $4.65 |
$4.75B |
$4.54B – $5.3B |
4 |
